Amyloid negativity in patients with clinically diagnosed Alzheimer disease and MCI
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Neurology (clinical)
Reference37 articles.
1. Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease
2. Florbetapir (F18‐AV‐45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging
3. Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
4. Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients
5. Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
Cited by 103 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. CAPS: a simple clinical tool for β-amyloid positivity prediction in clinical Alzheimer syndrome;Frontiers in Neurology;2024-08-14
2. Circulating Biomarkers for Alzheimer’s Disease: Unlocking the Diagnostic Potential in Low- and Middle-Income Countries, Focusing on Africa;Neurodegenerative Diseases;2024
3. Multiomics Blood-Based Biomarkers Predict Alzheimer’s Predementia with High Specificity in a Multicentric Cohort Study;The Journal of Prevention of Alzheimer's Disease;2024
4. DOSE: a lifestyle philosophy for dementia prevention informed by drug development and epidemiology;Dementia & Neuropsychologia;2024
5. Magnetic resonance image-based brain age as a discriminator of dementia conversion in patients with amyloid-negative amnestic mild cognitive impairment;Scientific Reports;2023-12-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3